Form S-4
Please disclose here and on the cover page when you will file the listing application for the combined company and whether the NYSE’s determination will be known at the time that stockholders are asked to vote to approve the business combination. Please revise to make clear whether the business combination is conditioned upon receiving NYSE listing approval.
No numbered answer found in the reply. Read the reply ↗
Please revise to identify which conditions to the completion of the business combination may be waived.
The Company respectfully acknowledges theRead in the reply
Staff’s comment. In response to the Staff’s comment, the Company has revised its disclosure on pages 21 and 162 of the Amended Registration Statement.
We note your disclosure on page (i) that you intend to implement a structure similar to that of an “Up-C” and will establish an intermediate subsidiary of the Company. Please expand your disclosure in the Summary to explain the business or strategic rationale for why this structure was selected, including any material ways in which the structure benefits the Company, the sponsor, the sellers or related parties.Rest of the question
Conflicts of interest related to such benefits should be discussed in the Risk Factors section. Please also disclose how the transaction structure achieves its intended benefits. You also state that sellers have the option to elect to receive equity consideration in the form of GSAH Class A common shares or “paired interests” comprised of GSAH Class B shares and Class B shares in your intermediate subsidiary. Further, you state on page 50 that you expect the sellers who are current members of Mirion’s management team to elect to receive paired interests. Please revise to explain the benefits of electing to receive paired interests that would not be shared with holders of GSAH Class A common shares generally.
The Company respectfully acknowledges the Staff’s comment. In response to the Staff’s comment, theRead in the reply
Company has revised its disclosure on page 34 of the Amended Registration Statement.
Please include a diagram of your organizational structure after giving effect to the business combination, including the anticipated ownership percentages of each entity and classes of stock. Address here the potential impact of the Option Agreement, as referenced on page 169.
The Company respectfully acknowledges the Staff’s comment. In response to the Staff’s comment, the Company has revised its disclosure on pages 35 of the Amended Registration Statement.Read in the reply
We note on page 41 you state that under the Business Combination Agreement, the Charterhouse parties must cause the holders of a majority of Mirion’s Class A ordinary shares and B ordinary shares to deliver an executed joinder agreement and election agreement, and on page 37 you state that a closing condition includes that a majority of the holders of the Class A ordinary shares and the B ordinary shares of MirionRest of the question
will have delivered the drag along notice. You describe the consideration to Mirion shareholders as consideration to sellers, which does not contemplate Mirion shareholders that do not sign a joinder agreement. Please revise to clearly explain what happens if one or more Mirion shareholders do not execute a joinder agreement.
The Company respectfully acknowledges the Staff’s comment. In response to the Staff’s comment, the Company has revised its disclosure on pages 39 and 42 of the Amended Registration Statement.Read in the reply
Please balance your disclosure with reference to Mirion’s history of losses and accumulated deficit as of March 31, 2021, as referenced on page 67.
The Company respectfully acknowledges the Staff’s comment. In response to the Staff’s comment, the Company has revised its disclosure on page 33 of the Amended Registration Statement.Read in the reply
Risks Factors
Risks Related to Our Business and Industry—We have, and we intend to continue pursuing, fixed-price contracts..., page 75
Please expand your disclosure to quantify the extent to which your business relies on fixed-price contracts.
The Company respectfully acknowledges the Staff’s comment. In response to the Staff’s comment, the Company has revised its disclosure on page 75 of the Amended Registration Statement.Read in the reply
We note your disclosure of the exclusive forum provision included in the New Marion Charter on pages 292-293 and in Annex B, which states that the provision does not apply to Securities Act claims. Please reconcile your disclosure here or advise.
The Company respectfully acknowledges the Staff’s comment. In response to the Staff’s comment, the Company has revised its disclosure on page 122 of the Amended Registration Statement.Read in the reply
Please expand your disclosure to clarify how you arrived at Mirion’s unaudited financial results for the twelve-month period ending December 31, 2020 (e.g. adding interim results for the six months ending December 31, 2020, and deducting the comparable preceding year’s interim results).Rest of the question
Provide any additional quantitative and narrative disclosure necessary to explain the effects of unusual charges or adjustments in these periods.
The Company respectfully acknowledges the Staff’s comment. The Company arrived at the unaudited financial results for the twelve-month period ending December 31, 2020 by aggregating the results for each quarterly period in calendar year 2020 (i.e., quarters endingRead in the reply
March 31, 2020, June 30, 2020, September 30, 2020, and December 31, 2020). In aggregating these results, the Company did not identify any unusual charges or adjustments that would require additional quantitative or narrative disclosure.Rest of the answer
In response to the Staff’s comment, the Company has revised its disclosure on page 128 to include the description of how the Company arrived at Mirion’s unaudited financial results for the twelve-month period ended
December 31, 2020.
Please revise page 168 to describe the approximate number of shares covered by the Amended and Restated Registration Rights Agreement.
The Company respectfully acknowledges the Staff’s comment. In response to the Staff’s comment, the Company has revised its disclosure on page 173 of the Amended Registration Statement.Read in the reply
Please revise page 177 to explain the basis for the Board's conclusion that Mirion is a top competitor in each of its end markets.
The Company respectfully acknowledges the Staff’s comment. In response to the Staff’s comment, theRead in the reply
Company has revised its disclosure on pages 182 of the Amended Registration Statement.
You indicate on pages 172 and 177 that you engaged a financial accounting firm and a third party consulting firm to provide market and financial due diligence, and the views of these consultants and financial and other advisors were considered by the Board in deciding to approve the business combination.Rest of the question
Please revise to further detail the scope of the engagement of such parties and to describe the analyses performed and information provided to the Board by such parties.
The Company respectfully acknowledges the Staff’s comment. In response to theRead in the reply
Staff’s comment, the Company has revised its disclosure on page 178 of the Amended Registration Statement.
Please revise to explain the basis for the $2.5 billion valuation for Mirion. Address in your revisions the methodology used by the Board in reaching the valuation and describe the extent to which the Board relied on the financial projections provided by Mirion.
The Company respectfully acknowledges the Staff’s comment. In response to the Staff’s comment, theRead in the reply
Company has revised its disclosure on page 179 of the Amended Registration Statement.
Your public disclosures indicate that a comparable company analysis was performed and that the valuation for the transaction was determined to be at a discount to peers. Please revise to discuss the extent to which the GSAH Board relied on such analysis and if material, revise to describe the underlying methodology, selection criteria, companies selected and conclusions of such analysis.Rest of the question
Include in your revisions whether any comparable companies meeting the selection criteria were excluded from the analysis, and, if so, the reasons for such exclusion.
The Company respectfully acknowledges the Staff’s comment. In response to the Staff’s comment, the Company has revised its disclosure on page 181 of the Amended Registration Statement.Read in the reply
Please revise to provide a more detailed description of the process used in eliminating potential business combination candidates as you progressed from hundreds of candidates to Mirion. Please provide more detail on these other potential targets, including with respect to the 17 companies that executed NDAs, details concerning their industries, size and why discussions ended, including on a company-by-company basisRest of the question
for the companies that reached the most advanced discussions.
The Company respectfully acknowledges the Staff’s comment. In response to the Staff’s comment, the Company has revised its disclosure on pages 175 and 176 of the Amended Registration Statement.Read in the reply
You state that the material assumptions underlying the projections include, but are not limited to, the items in the bulleted list on page 178-179. Please revise to describe all material assumptions.
The Company respectfully acknowledges the Staff’s comment. In response to the Staff’s comment, the Company has revised its disclosure on page 186 of the Amended Registration Statement.Read in the reply
On page 179 you state that the assumed growth rate was estimated in partnership with a global consulting firm. Please expand your discussion to provide more details concerning how this rate was determined, including underlying assumptions and any comparable companies considered.
The Company respectfully acknowledges the Staff’s comment. In response to the Staff’s comment, the Company has revised itsRead in the reply
Please expand this tax disclosure beginning on page 186 to include discussion of the material tax considerations with respect to the business combination, including ownership and disposition of shares of New Mirion common stock and public warrants after the business combination.
The Company respectfully advises the Staff that the material U.S. federal income tax consequences to the Company’s shareholders with respect to the business combination have been adequately disclosed in the Registration Statement. Because the Company and New Mirion are treated as the same company for U.S.Read in the replyRest of the answer
federal income tax purposes, the Company believes expanding the section of the Registration Statement discussing the material tax considerations to the Company’s shareholders to include information related to the ownership and disposition of shares of New Mirion common stock and public warrants is unnecessary because such information has already been disclosed in the Registration Statement on Form S-1 (Registration No. 333-239096) filed with the Commission on
June 24, 2020.
The Company is not aware of any disclosures regarding similarly situated companies and shareholders (i.e., an acquisition by a special purpose acquisition company (a “SPAC”) of a target company in which the only exchange involving the SPAC shareholders is an exercise of such shareholders’ redemption rights) which include the information requested by Staff in the Comment Letter. In light of similar Form S-4 disclosures previously and recently approved by the Staff, the Company does not believe that the Registration Statement would be enhanced by including the information requested by the Staff, particularly when such information is already disclosed and available to holders of the Company stock and warrants in the Company’s Form S-1.
Please revise the bottom of page 225 and the top of page 226 to state the amount of indebtedness Mirion held at the periods described.
The Company respectfully acknowledges the Staff’s comment. In response to the Staff’s comment, theRead in the reply
Company has revised its disclosure on page 234 to state the amount of indebtedness Mirion held at the periods described.
Please revise this section to briefly describe the meaning of scientific or technical terms, including dosimetry services, dosimeters, alpha spectroscopy instruments, alpha/beta counting instruments and gamma spectroscopy detector systems and software and phantoms.
The Company respectfully acknowledges the Staff’s comment. In response to the Staff’s comment, the Company has revised its disclosure on page 235 of the Amended Registration Statement.Read in the reply
Please revise page 233 to describe the adjacent markets that you believe you can expand into and the basis for your claim such markets represent a $17 billion annual revenue market opportunity.
The Company respectfully acknowledges the Staff’s comment. In response to the Staff’s comment, the Company has revised its disclosure on page 243 of the Amended Registration Statement.Read in the reply
Please revise your intellectual property discussion on page 237 to (i) specify the specific products, product groups and technologies to which such patents relate, (ii) describe whether the patents are owned or licensed, (iii) detail the type of patent protection and (iv) identify the foreign jurisdictions covered.Rest of the question
Additionally, please segregate patent expiry for issued patents and patent applications and with respect to patents expected to expire in 2021, revise to disclose whether such expiry is expected to have a material impact on your business.
The Company respectfully acknowledges the Staff’s comment. In response to the Staff’s comment, the Company has revised its disclosure on page 247 of the Amended Registration Statement of the Amended Registration Statement.Read in the reply
Please revise to disclose your competitors and describe competitive conditions in the markets in which you operate.
The Company respectfully acknowledges the Staff’s comment. In response to the Staff’s comment, the Company has revised its disclosure on page 245 of the Amended Registration Statement.Read in the reply
Please revise to provide the outstanding equity awards at fiscal year-end table required by Item 402(f) of Regulation S-K.
The Company respectfully acknowledges the Staff’s comment. In response to the Staff’s comment, the Company has revised its disclosure on page 295 of the Amended Registration Statement.Read in the reply
Please revise to provide the approximate number of holders of each class of Mirion ordinary shares as required by Item 201(b) of Regulation S-K as referenced in Item 17(b) of Form S-4.
The Company respectfully acknowledges the Staff’s comment. In response to the Staff’s comment, the Company has revised its disclosure on page 303 of the Amended Registration Statement.Read in the reply
Please revise page 320 to disclose whether the 2016 Co-Investment Agreement survives the closing of the business combination. 1. Nature of Business and Summary of Significant Accounting Policies
The Company respectfully acknowledges the Staff’s comment. In response to theRead in the reply
Staff’s comment, the Company has revised its disclosure on page 336 of the Amended Registration Statement.
1. Nature of Business and Summary of
You note that in most cases your installation services represent a separate performance obligation recognized over time. Please provide us with additional details to help us understand why installation services are recognized over time rather than a point in time. In this regard, tell us the period of time installation services are generally provided. Financial Statements of Mirion Technologies (TopCo), Ltd.Rest of the question
and Subsidiaries 15. Segment Information, page F-76
The Company respectfully acknowledges the Staff’s comment. Installation services relate to the routine installation of equipment at the customer’s site. The associated revenues are recognized over time because the customer simultaneously receives and consumes the benefits provided by the Company’s performance as the Company performs, and therefore meets a criteria per ASC 606-10-25-27 to be recognized over time. Installation services generally occur over a period that is less than a month.Read in the reply
Financial Statements of Mirion Technologies (TopCo), Ltd. and Subsidiaries
15.Rest of the answer
Segment Information, page F-76
Please tell us what consideration was given to further disaggregating each of your segment revenues by major product categories as noted on page 234.
to the Staff’s comment, beginning with the Company’s annual financial statements for the year ended June 30, 2021, which the Company anticipates filing with the next amendment to the FormRead in the reply
S-4, the Company intends prospectively to present revenue disaggregated by the following product categories:
Medical,
Reactor safety and control systems, and
Radiological search, measurement, and analysis systems.
Each of our product categories and aggregation considerations are described in the following paragraphs.Rest of the answer
While ASC 280-10-50-40 does not provide guidance for determining if products are similar, the Company determined the appropriate level of aggregation of these products and service using the segment aggregation criteria in ASC 280-10-50-11 by analogy.
Medical
The products and services included in this product category address needs in cancer diagnostics and therapeutics QA, nuclear medicine, medical imaging, dosimetry, and rehabilitation. The Company considered the aggregation criteria for products and services in this product category as follows:
(a) Nature of the products: The nature of the products and services and the need that they address are similar. All products and services relate to medical devices or associated software and services that are focused on enhancing the effectiveness and safety of life-saving procedures.
(b) Nature of the production processes: For substantially all of the products in this category, the products are manufactured and assembled by the Company using a combination of parts sourced from third parties and produced in-house.
(c) Type or class of customer: For substantially all of the products and services in this category, the end customers consist of medical facilities (i.e., hospitals, clinics / urgent care facilities, dental offices, and veterinary offices), medical facilities supply chain (e.g., drug manufacturers and pharmacies), medical research facilities, and universities.
(d) Distribution methods: For substantially all of the products in this category, the Company uses a combination of direct sales and a network of distribution partners.
(e) Regulatory environment: Our medical products and services are sold in countries across the world, and most are regulated as medical devices by regulatory bodies in each respective country (e.g., the U.S. Food and Drug Administration (“FDA”) in the United States).
Based on the preceding, the Company believes that the products and services included in the Medical segment together represent a similar group of products and services and are properly presented as a major product category.
The products and services included in the Industrial segment consist of two groups of similar products and services. These are (1) Reactor Safety and Control Systems and (2) Radiological Search, Measurement and Analysis Systems. The aggregation criteria for the products included in each of these are considered below.
Reactor Safety and Control Systems
The products and services included in this product category consist of radiation monitoring systems, reactor instrumentation and control equipment and systems, and neutron flux measurement systems. The Company considered the aggregation criteria for products and services in this product category as follows:
(a) Nature of the products: The nature of the devices is similar and so is the need that they address. All products relate to radiation monitoring systems and reactor instrumentation and control systems that ensure the safe operation of nuclear reactors and other nuclear fuel cycle facilities.
(b) Nature of the production processes: For substantially all of the products in this category, the products are manufactured and
(c) Type or class of customer: For substantially all of the products and services in this category, the customers are nuclear power plants and other customers operating nuclear reactors (e.g., military and research laboratories).
(d) Distribution methods: For substantially all of the products and services in this category, sales are made directly to customers.
(e) Regulatory environment:
The products are subject to government regulations in each respective country where products are sold.
Based on the preceding, the Company believes that the products and services included in the Reactor Safety and Control Systems product category together represent a similar group of products and services.
Radiological Search, Measurement and Analysis Systems
The products and services included in this product category consist of dosimeters, contamination and clearance monitors, detection and identification devices, customized research detectors, environmental monitoring systems, radiochemistry instruments, imaging systems, waste measurement devices, and related services. The Company considered the aggregation criteria for products and services in this product category as follows:
that they address. All products are used to locate, measure, and perform in-depth scientific analysis of radioactive sources or material for radiation safety, security, and scientific applications.
(b) Nature of the production processes: For substantially all of the products in this category, the products are manufactured and
(c) Type or class of customer: For substantially all of the products and services in this category, customers are in the government, military, nuclear, education, and research sectors.
(d) Distribution methods: For substantially all of the products and services in this category, the Company uses a combination of direct sales and a network of distribution partners.
the products and services included in the Radiological Search, Measurement, and Analysis Systems product category together represent a similar group of products and services.
Please disclose revenues from external customers for each product and service or each group of similar products and services as required by ASC 280-10-50-40 or tell us why and disclose it is impracticable to do so.
The Company respectfully acknowledges the Staff’s comment. Please see response to comment 28. In response to the Staff’s comment, beginning with the Company’s annual financial statements for the year ended June 30, 2021, which the Company anticipates filing with the next amendment to the Form S-4, the Company intends prospectively to present revenue disaggregated by the following product categories:Read in the reply
You note that you recognize revenues for hardware installation when control and benefit transfer to the customer, which occurs over time as the installation service is completed. Please help us understand your policy by providing us with additional information, such as how long installation generally takes.
The Company respectfully acknowledges the Staff’s comment. Hardware installation services relate to the routine installation of equipment at the customer’s site. The associated revenues are recognized over time because the customer simultaneously receives and consumes the benefits provided by the Company’s performance as the Company performs, and therefore meets a criteria per ASC 606-10-25-27 to be recognized over time. Hardware installation services generally occur over a period of a few days.Read in the reply
Please file the Charterhouse Director Nomination Agreement, the GS Director Nomination Agreement and any documentation concerning the Profits Interests as exhibits pursuant to Item 601 of Regulation S-K.
The Company respectfully acknowledges the Staff’s comment. In response to the Staff’s comment, the Company has filed as exhibits the Charterhouse Director Nomination Agreement, the GS Director Nomination Agreement and Profits Interest Award Agreements with each ofRead in the reply
Thomas Logan, Brian Schopfer and Lawrence Kingsley.
[Remainder of Page Intentionally Left Blank]
Should any questions arise in connection with the filing or this response letter, please contact the undersigned at 212-310-8552 or by e-mail at [email protected].
Please revise footnote 5 on pages 20, 52 and 138, and footnote 4 on pages 53 and 139, to describe how the Option Agreement could affect the ownership shown in the Cash Shortfall situation.
The Company respectfully acknowledges the Staff’s comment. In response to the Staff’s comment, the Company has revised the disclosure on pages 20, 55, 56, 143 and 144 of the Amended Registration Statement.Read in the reply
We note that the PIK Notes are defined as the Shareholder Notes and the Management Notes, both of which are contemplated to be repaid upon closing. New disclosure on page 18 and elsewhere states that the consideration to be paid to the Mirion Sellers in connection with the Business Combination will be allocated first in respect of the PIK Notes and second in respect of the Existing Mirion Shares.Rest of the question
You also state that the PIK Notes accrue payment-in-kind interest daily at a rate of 11.5% annually and are contemplated to be sold at the Closing for a price equal to the full outstanding principal amount together with all accrued but unpaid interest up to but excluding the Closing Date. You also mention that as the amount of accrued and unpaid interest increases, the holders of the PIK Notes will receive more consideration as compared to the holders of the Existing Mirion Shares. This has the effect over time of increasing the amount of shares of GSAH Class A Common Stock to be issued to the Mirion Sellers (excluding members of Mirion management) and reducing the number of shares of GSAH Class B common stock that will be issued to Mirion management. Please revise to clarify whether you are selling PIK Notes at the Closing or simply repaying existing PIK Notes, reconcile your disclosure that the PIK Notes accrue interest at 11.5% given elsewhere you state the Management Notes accrue interest at 5.75%, and explain how the increase in shares of GSAH Class A Common Stock pursuant to the PIK notes results in fewer shares of GSAH Class B Common Stock being issued.
The Company respectfully acknowledges the Staff’s comment. In response to the Staff’s comment, the Company has revised the disclosure on pages 18, 53, 132, 142 and 327 of the Amended Registration Statement.Read in the reply
We note your response to our prior comment 3, which we reissue. The advantages of the structure that you cite, such as control over the operating entities, a combined return and allowing existing shareholders the same voting power commensurate with their economic interests, appear to be present in other common SPAC acquisition structures.Rest of the question
Please expand your disclosure in the Summary to specifically explain how this structure provides benefits unique to this structure. Please also revise to specifically explain the benefits of electing to receive paired interests that would not be shared with holders of GSAH Class A common shares generally, and why you expect Sellers (except for Mirion’s management) to elect to receive GSAH Class A shares while Mirion’s management will elect to receive Paired Interests. Also please revise the ownership structure chart to clarify whether Mirion management are expected to own the other <20% of IntermediateCo Class B common stock.
The Company respectfully acknowledges the Staff’s comment. In response to the Staff’s comment, the Company has revised the disclosure on pages 35 and 37 of the Amended Registration Statement.Read in the reply
Please tell us how your presentation of Mirion’s unaudited financial results for the twelvemonth period ending December 31, 2020 complies with Item 11-02(c)(3) of Regulation S- X. Tell us if there would be any material differences if you used amounts arrived at by adding subsequent interim results to the audited fiscal year's data and deducting the comparable preceding year's interim results.
TheRead in the reply
Company respectfully acknowledges the Staff’s comment. The Company concluded that the method of aggregating the results for each quarterly period in calendar year 2020 (i.e., quarters ending March 31, 2020, June 30, 2020,
September 30, 2020, and December 31, 2020) resulted in the same result as adding subsequent interim results to the audited fiscal year’s data and deducting the comparable preceding year’s interim results in accordance with Item 11-02(c)(3) of Regulation S-X.
In response to the Staff’s comment, the
Company has revised its disclosure on page 133.
We note your response to our prior comment 10. Please revise page 173 to state whether the founder shares will be afforded registration rights if they vest.
The Company respectfully acknowledges the Staff’s comment.Read in the reply
In response to the Staff’s comment, the Company has revised the disclosure on page 177 of the Amended Registration Statement.
We note your response to our prior comment 13, which we reissue in part. Please revise page 178 to provide the quantitative figures that resulted from the valuation methodologies relied on by the Board, such as the DCF analysis.
The Company respectfully acknowledges the Staff’s comment. In response to the Staff’s comment, the Company has revised its disclosure on page 182 of the Amended Registration Statement.Read in the reply
We note your response to our prior comment 14, which we reissue in part. Please revise pages 181-182 to provide more information concerning the peer company analysis, including the time period for the data used to calculate enterprise value, whether you used EBITDA as calculated by the peer company in its public filings or calculated by another method, and whether any of the EBITDA figures used for comparison wereRest of the question
calculated differently than Mirion’s EBITDA. Mirion Technologies (TopCo), Ltd. Notes to Consolidated Financial Statements 1. Nature of Business and Summary of Significant Accounting Policies
The Company respectfully acknowledges the Staff’s comment. In response to the Staff’s comment, the Company has revised its disclosure on page 185 of the Amended Registration Statement.Read in the reply
Please explain how you meet the criteria under ASC 606-10 paragraphs 55-5 through 55-6 regarding how the customer simultaneously receives and consumes the benefits as the installation services are performed. In this regard, disclose, if true, that the equipment is being used without the installation being completed and/or that another entity could complete the installation services at any point in time of theRest of the question
installation. Financial Statements of Mirion Technologies (TopCo), Ltd. and Subsidiaries 15. Segment Information, page F-76
The Company respectfully acknowledges the Staff’s comment. Installation services are considered routine, as contemplated under ASC 606-10-55-5. Further, considering the requirements of ASC 606-10-55-6, we determined that another entity would not need to substantially reperform the work that the entity has completed to date if that other entity were to fulfill the remaining performance obligation to the customer. Customers can choose to engage either the Company or other third parties to perform installations.Read in the replyRest of the answer
Installation services can be performed by other entities at any point in time during the installation process. The Company has updated the revenue recognition disclosure within footnote 1 of the financial statements on page F-52 accordingly.
Financial Statements of Mirion Technologies (TopCo), Ltd. and Subsidiaries
15. Segment Information, page F-76
We noted that you removed your presentation of revenue disaggregated by product categories on page F-79 of your initial Form S-4 filing. As you have stated in your correspondence that you intend to present revenue disaggregated by product categories in an amendment to Form S-4, please also provide the disclosure for prior periods as previously presented.
TheRead in the reply
Company respectfully acknowledges the Staff’s comment. The Company notes that disclosures on page F-79 of the initial Form S-4 filing and of Amendment No. 1 to
Form S-4 are consistent. The Company has included revenue disaggregated by the following product categories on page F-83 of our amended
S-4 filing for all periods presented: Medical; Reactor Safety and Control Systems; and Radiological Search, Measurement, and Analysis Systems.
Please file as exhibits the Confidentiality and Intellectual Property Agreement attached as an exhibit to the Logan Employment Agreement, as well as the Confidentiality, Non- Interference and Intellectual Property Agreement, attached to each of the Freed Employment Agreement and Schopfer Employment Agreement. Refer to Item 601(b)(10) of Regulation S-K.
The Company respectfully acknowledges the Staff’s comment. In response to the Staff’s comment, the Confidentiality and Intellectual Property Agreement attached as an exhibit to the Logan Employment Agreement, as well as the Confidentiality, Non-Interference and Intellectual Property Agreement, attached to each of the Freed Employment Agreement and Schopfer Employment Agreement have been filed as exhibits to the Amended Registration Statement.Read in the reply
[Remainder of Page Intentionally Left Blank]
Should any questions arise in connection with the filing or this response letter, please contact theRest of the answer
undersigned at 212-310-8552 or by e-mail at [email protected].
In the risk factors on pages 85 you state that you have been subject to a failure or breach of your or your vendors’ information technology, data security infrastructure, or the security infrastructure of your products, or the discovery or exploitation of defects or vulnerabilities in the same, and on page 103 you state that you have been subject to product recalls.Rest of the question
Please revise to provide the details of such events, including when such events occurred.
The Company respectfully acknowledges the Staff’s comment. With respect to the Staff’s comment regarding a failure or breach of Mirion’s or Mirion’s vendors’ information technology, data security infrastructure, or the security infrastructure ofRead in the reply
Mirion’s products, or the discovery or exploitation of defects or vulnerabilities in the same, the Company respectfully advises the Staff that the details of such events have been disclosed on page 85 of the Amended Registration Statement, and there are no further such events to disclose.Rest of the answer
In response to the Staff’s comment with respect to product recalls, the Company has revised the disclosure on page 103 of the Amended Registration Statement.
We note your response to our prior comment number 6. In order for an investor to evaluate the Board's process in approving the terms of the Business Combination, please revise to provide the full quantitative DCF analysis (including e.g., the sensitivities applied to Mirion's business and related assumptions) and the EBITDA figures used in the peer analysis.
The Company respectfully acknowledges the Staff’s comment. In response to theRead in the reply
Staff’s comment, the Company has revised the disclosure on pages 183, 184, 185 and 187 of the Amended Registration Statement.
We note your disclosure concerning the lawsuit filed by Tim Holtom on page 207. Please revise to more specifically explain the allegations in the complaint. Address in your revisions the factual basis alleged to underlie each of the plaintiff's claims. Refer to Item 103 of Regulation S-K.
The Company respectfully acknowledges the Staff’s comment. In response to the Staff’s comment, the Company has revised the disclosure on pages 65, 66, 129, 130, 210 and 211 of the Amended Registration Statement.Read in the reply
Please revise the preliminary proxy card to clarify that the approval of certain proposals are conditioned upon the approval of other specified proposals. See Rule 14a-4(a)(3) of Regulation 14A.
The Company respectfully acknowledges the Staff’s comment. In response to the Staff’s comment, the Company has revised the preliminary proxy card.Read in the reply
[Remainder of Page Intentionally Left Blank]
Should any questions arise in connection with the filing or this response letter, please contact the undersigned at 212-310-8552 or by e-mail at [email protected].
We note your response to comment 2 and the revisions on page 186 concerning the DCF analysis for the years 2021-2031. Please revise to explain how you considered the speculative nature of projections over such an extended period.
The Company respectfully acknowledges the Staff’s comment. In response to the Staff’s comment, the Company has revised the disclosure on page 186 of the Amended Registration Statement.Read in the reply
[Remainder of Page Intentionally Left Blank]
Should any questions arise in connection with the filing or this response letter, please contact the undersigned at 212-310-8552 or by e-mail at [email protected].
Also in this review: company letter, Sep 28, 2021, company letter, Nov 2, 2021